logo

For the Inventor, By the Inventor

Tromso, Norway

Biotec Pharmacon Asa


USPTO Granted Patents = 21

% Expired Patents = 38.1



Trademarks = 4

Forward Citations = 61

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Rolf Einar Engstad (12 out of 20 patents)

silverMedal Olav Lanes (6 out of 11 patents)

bronzeMedal Rolf Seljelid (4 out of 4 patents)

4.  Dag Rune Gjellesvik (3 out of 3 patents)

5.  Bernd Fabry (3 out of 60 patents)

6.  Rolf Wachter (3 out of 21 patents)

7.  Ute Griesbach (3 out of 9 patents)

8.  Nai-Kong V Cheung (2 out of 56 patents)

9.  Terese Solstad (2 out of 5 patents)

10.  Marit Sjo Lorentzen (2 out of 6 patents)

11.  Morten Elde (2 out of 5 patents)

12.  Thor Nøkland (2 out of 2 patents)

13.  Gunnar Rorstad (2 out of 9 patents)

14.  Bjørn Altermark (2 out of 3 patents)

15.  Dag-Eirik Ramsøy (2 out of 3 patents)


21 patents:

1. 10646506 - Glucans (2020-05-12),
2. 9750688 - Glucan gels (2017-09-05),
3. 9650618 - Endonucleases (2017-05-16),
4. 9623043 - Glucans (2017-04-18),
5. 9422595 - Endonucleases (2016-08-23),
6. 9314432 - Glucan gels (2016-04-19),
7. 9211304 - Therapy-enhancing glucan (2015-12-15),
8. 9133447 - Method of removing nucleic acid contamination in reverse transcription and amplification reactions (2015-09-15),
9. 8946193 - Medical uses of glucans (2015-02-03),
10. 8912165 - Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents (2014-12-16),
11. 8551753 - Method of removing nucleic acid contamination in reverse transcription and amplification reactions (2013-10-08),
12. 8501710 - Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents (2013-08-06),
13. 8323644 - Therapy-enhancing glucan (2012-12-04),
14. 8142785 - Method or use of a solubilized glucan product to increase immunostimulation in animals (2012-03-27),
15. 7323325 - Shrimp alkaline phosphatase (2008-01-29),
Company Overview
Biotec Pharmacon Asa, based in Tromso, Norway, specializes in the development and manufacturing of innovative biopharmaceuticals. The company focuses on leveraging its expertise in immunology and biotechnology to create products aimed at enhancing immune responses and improving health outcomes. With a commitment to research and development, Biotec Pharmacon Asa is dedicated to advancing therapeutic solutions that address various medical needs, particularly in the fields of infectious diseases and immune-related conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Biotec Pharmacon Asa USPTO Patent Assignee Logo
21 Patents

#1 in Tromso

#79 in Norway

#30,001 in the World

Tromso, NO
Tromso, Norway

Biotec Pharmacon Asa

Forward Citations = 61

27 inventors:

goldMedal Rolf Einar Engstad (12 out of 20 patents)

silverMedal Olav Lanes (6 out of 11 patents)

bronzeMedal Rolf Seljelid (4 out of 4 patents)

4.  Dag Rune Gjellesvik (3 out of 3 patents)

5.  Bernd Fabry (3 out of 60 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biotec Pharmacon Asa. Retrieved from https://idiyas.com/company/biotec-pharmacon-asa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…